#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary biliary cholangitis Neuroendocrine cell hyperplasia of infancy Philadelphia positive chronic myeloid leukaemia Postprandial hypoglycaemia Epstein-Barr virus associated lymphoproliferative disorder Cortical dysplasia Cold type haemolytic anaemia Frostbite Alveolar proteinosis Acute leukaemia Essential thrombocythaemia Congenital pseudarthrosis Mantle cell lymphoma Pyoderma gangrenosum Immune-mediated myasthenia gravis More trials…

    Learn about Rare Diseases

    Ehlers-Danlos syndrome – Basic Information Myelodysplastic syndrome – Treatment Antisynthetase syndrome Chondrosarcoma – Basic Information Glycogen storage disease type V – Life with Disease Indolent systemic mastocytosis – Treatment KBG syndrome – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Biotinidase deficiency – Diagnostics Cystic fibrosis lung – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Glasdegib Diltiazem Hydrochloride Sacubitril Alclometasone Dipropionate Lansoprazole Stx-241 Gs-5718-03 Trazodone Phenylephrine Gsk4004280 Enmetazobactam Camphor Rp-1664 Sulfate GSKVX000000030825 Water For Injection Glyceryl Trinitrate Lisinopril Dihydrate Amiodarone Hydrochloride Methotrexate Nirogacestat Hydrobromide More therapies…

    Learn about Your Condition

    Fontan procedure Low cardiac output syndrome Arteriovenous malformation Delayed graft function Myofascial pain syndrome Neuralgia Endometrial cancer stage III Post procedural swelling Bartonellosis Rhabdoid tumour Pulmonary resection Bladder cancer stage III Aneurysm ruptured Persistent depressive disorder Oesophageal adenocarcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Early switch to oral amoxicillin (drug combination) for adults with vertebral osteomyelitis: a randomised non‑inferiority trial

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefalexin
    • Ciprofloxacin
    • Flucloxacillin
    Germany

  • Efficacy and Safety of LTG-321 Compared with Placebo in Patients with Osteoarthritis of the Knee

    Recruiting

    2 1
    Investigated Diseases:
    • Osteoarthritis
    Denmark

  • Safety and Tolerability of Intrathecal TRCN-1023 in Adults with Amyotrophic Lateral Sclerosis (ALS) – Randomized Placebo‑Controlled Phase 1/2 Trial

    Recruiting

    1 1
    Germany The Netherlands

  • Long‑Term Safety and Efficacy Study of ENTR‑601‑45 and ENTR‑601‑44 in Participants with Duchenne Muscular Dystrophy

    Recruiting

    2 1 1
    Belgium Italy The Netherlands Spain

  • Efficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica

    Recruiting

    3 1 1
    Investigated Drugs:
    • Sarilumab
    • Prednisone
    Austria Belgium Czechia France Germany Greece +3

  • Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DNL952 in Adults with Late‑Onset Pompe Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Germany The Netherlands
1 2 3 … 68
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!